Dendreon

Sector:
Healthcare

Location:
Seattle, WA

Year Funded:
1996

Status:
IPO

Website:
www.dendreon.com


Summary:
Dendreon Corporation is a biotechnology company whose mission is to find new treatments for cancer through the discovery, development and commercialization of novel therapeutics. Its lead product, Provenge, is the first immunotherapy approved by the FDA for the treatment of prostate cancer.